incretin mimetic agents glp 1 receptor agonists and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease Frontiers | GLP−1 receptor agonists

This will improve both, the periprocedural safety and efficacy of EGDs, in patients taking GLP-1 RAs

Clinical trials did not include pregnant or breastfeeding women, children, elderly individuals over 65, or those with active malignancy or severe organ dysfunction

Proc Natl Acad Sci USA 98:23232328 Xu C, Zhang X, Yu C, Lu G, Chen S, Xu L, Ding W, Shi Q, Li Y (2009) Proteomic analysis of hepatic ischemia/reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5beta

The long-term use of GLP-1RAs can reduce the risk of MALE in TD patients, thereby improving prognosis

In vivo studies Regarding the effects of iodine excess on oxidative stress even more studies have been performed in in vivo conditions